ImpediMed Limited (ASX:IPD) Announces Q3 Revenue and ARR Growth
Financial Performance
ImpediMed Limited reported record unaudited total revenue of A$3.4 million for Q3 FY25, up from A$3.3 million in Q2 FY25. The Core Business Total Contracted Value (TCV) increased to A$4.9 million, and the Annual Recurring Revenue (ARR) rose to A$13.7 million. Cash receipts reached a record A$4.1 million, while net operating cash outflows were A$3.5 million. The company maintains a cash balance of A$27.9 million, equating to 8.1 quarters of operating cash flow.
Management Changes
Scott Long has been appointed as the new Senior Vice President of Sales, replacing Tim Benkovic. Scott brings over 30 years of experience in breast cancer medical device sales, enhancing the company’s leadership as it implements its new go-to-market strategy.
Sales and Marketing Update
The company experienced record lead generation with over 500 new leads identified. Efforts are now focused on converting these opportunities into sales, with expectations of a significant increase in SOZO unit sales throughout the year. Increased media activity and conference attendance have driven awareness and supported clinical adoption.
Cash Flow and Financial Position
ImpediMed recorded net cash outflows from operating activities of A$3.5 million, supported by record cash receipts of A$4.1 million. The cash balance increased following the drawdown of A$10 million from a A$15 million growth capital facility. Staff costs and higher advertising investments were the primary drivers of cash outflows.
Motley Fool contributor Lauren Surplice has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
